Lonza (Switzerland), Merck (Germany) and Thermo Fisher Scientific Inc. (US) are top players in Viral Vector Manufacturing Market
The global viral vector manufacturing market is projected to reach USD 12.8 billion by 2028 from USD 5.5 billion in 2023, at a CAGR of 18.2%. This market is consolidated in nature with a few global players. In 2017, Lonza (Switzerland), Merck (Germany), and Oxford …